JPMorgan Chase & Co. grew its stake in shares of HealthStream, Inc. (NASDAQ:HSTM - Free Report) by 82.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 104,468 shares of the technology company's stock after buying an additional 47,264 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.34% of HealthStream worth $3,322,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of HSTM. Lee Danner & Bass Inc. bought a new stake in shares of HealthStream in the fourth quarter worth $183,000. Woodmont Investment Counsel LLC bought a new stake in shares of HealthStream in the 4th quarter valued at about $275,000. Diversified Trust Co increased its stake in shares of HealthStream by 20.5% in the fourth quarter. Diversified Trust Co now owns 8,733 shares of the technology company's stock valued at $278,000 after buying an additional 1,486 shares during the period. Natixis Advisors LLC bought a new position in shares of HealthStream during the fourth quarter worth about $331,000. Finally, Sanctuary Advisors LLC raised its position in shares of HealthStream by 11.7% during the third quarter. Sanctuary Advisors LLC now owns 14,737 shares of the technology company's stock worth $425,000 after acquiring an additional 1,538 shares during the last quarter. 69.58% of the stock is currently owned by institutional investors and hedge funds.
HealthStream Stock Performance
HSTM stock traded up $0.09 during midday trading on Friday, reaching $33.30. 57,645 shares of the company's stock traded hands, compared to its average volume of 131,583. HealthStream, Inc. has a 52 week low of $25.39 and a 52 week high of $34.24. The company has a 50-day moving average price of $32.21 and a two-hundred day moving average price of $31.79. The firm has a market capitalization of $1.02 billion, a PE ratio of 51.02, a price-to-earnings-growth ratio of 4.37 and a beta of 0.42.
HealthStream (NASDAQ:HSTM - Get Free Report) last announced its quarterly earnings results on Monday, February 24th. The technology company reported $0.16 EPS for the quarter, beating the consensus estimate of $0.13 by $0.03. HealthStream had a net margin of 6.84% and a return on equity of 5.67%. The firm had revenue of $74.24 million during the quarter, compared to the consensus estimate of $73.55 million. During the same period last year, the firm earned $0.14 EPS. As a group, analysts predict that HealthStream, Inc. will post 0.63 EPS for the current fiscal year.
HealthStream Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Monday, March 10th were issued a dividend of $0.031 per share. This is a positive change from HealthStream's previous quarterly dividend of $0.03. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.37%. The ex-dividend date of this dividend was Monday, March 10th. HealthStream's dividend payout ratio is currently 18.18%.
Analysts Set New Price Targets
HSTM has been the subject of several analyst reports. JMP Securities restated a "market perform" rating on shares of HealthStream in a report on Thursday, February 6th. Canaccord Genuity Group lifted their target price on shares of HealthStream from $29.00 to $30.00 and gave the stock a "hold" rating in a research note on Wednesday, February 26th. Finally, William Blair reaffirmed an "outperform" rating on shares of HealthStream in a research report on Tuesday, February 25th. Two analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, HealthStream has a consensus rating of "Moderate Buy" and an average price target of $32.00.
View Our Latest Research Report on HealthStream
HealthStream Company Profile
(
Free Report)
HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.
See Also

Before you consider HealthStream, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthStream wasn't on the list.
While HealthStream currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.